Gastric Cancer, a joint official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, publishes significant studies related to stomach neoplasms. The journal welcomes original articles, case reports, short communications, and technical notes, which will be peer-reviewed by the editorial board. Letters to the Editor commenting on articles published in the journal or expressing views on topics concerning gastric cancer are also welcomed. Review articles are in principle solicited by the Editor. Meeting reports will include summaries of symposia or consensus achieved in the congresses of related associations.
《胃癌》是国际胃癌协会和日本胃癌协会的联合官方期刊，发表与胃肿瘤相关的重要研究。该杂志欢迎原创文章，病例报告，简短的通信，和技术说明，这将是同行评议的编委会。我们也欢迎读者来信评论杂志上发表的文章或表达对胃癌相关话题的看法。评论文章原则上由编辑征集。会议报告将包括专题讨论会的摘要或相关协会大会达成的共识。
Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00929-9
Peritoneal metastasis in gastric cancer: results from the German database
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00978-0
Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501)
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00941-z
IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00976-2
DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial–mesenchymal transition in gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01002-1
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00999-9
The predictive value of the preoperative C-reactive protein–albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00936-w
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00967-3
Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00965-5
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00973-5
LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01019-6
The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00969-1
Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01000-3
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607)
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00991-3
Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00977-1
Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002)
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01007-w
Risk stratification for lymph node metastasis using Epstein–Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00963-7
Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00954-8
MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00924-0
Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01029-4
Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01022-x
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00953-9
Duodenal stump reinforcement might reduce both incidence and severity of duodenal stump leakage after laparoscopic gastrectomy with Roux-en-Y reconstruction for gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00946-8
Surgical outcomes and risk assessment for anastomotic complications after laparoscopic proximal gastrectomy with double-flap technique for upper-third gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00940-0
A genetic origin for acid–base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00982-4
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01008-9
Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00930-2
A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00962-8
Where does signet-ring cell carcinoma come from and where does it go?
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00960-w
GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00943-x
Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01014-x
Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer?
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00951-x
Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00935-x
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00966-4
Adherence with operative standards in the treatment of gastric cancer in the United States
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01028-5
Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01005-y
Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysis
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01012-z
Survival after neoadjuvant approaches to gastroesophageal junction cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00980-6
The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00964-6
Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00975-3
Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01017-8
Correction to: Oncological safety of proximal gastrectomy for T2/T3 proximal gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00955-7
Hedgehog signalling pathway activation in gastrointestinal stromal tumours is mediated by primary cilia
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00984-2
JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01024-9
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01021-y
Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00990-4
A message from the new editor-in-chief
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01020-z
Report about the present condition of Billroth’s stomach specimens
来源期刊：Gastric CancerDOI：10.1007/s10120-019-00987-z
Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01013-y
Assessment of lymphatic flow based on the sentinel node concept in early gastric adenocarcinoma that satisfies expanded endoscopic resection criteria
来源期刊：Gastric CancerDOI：10.1007/s10120-019-01026-7
